Press What’s news at AbelsonTaylor Group
Select category
Leveraging Multi-Touch Attribution for Greater Brand Marketing Success
Even in the present age of AI, big data and omnichannel marketing, pharma brands—for the most part—are stuck to the traditional idea that the last touch, the last communication someone receives before converting, should get all, or most of the credit for that conversion. Or, they might not even know which touchpoints to attribute credit.
In her article in Muse by Clio, Rebecca Visconti, VP of Marketing Intelligence, looks beyond that conventional worship of the last touch to provide evidence-based methods to calculate the real impact of every touchpoint more accurately.
Read the full article at Muse by Clio
Media Contact:
Recent Posts
Annual Report Healthcare Communications Agencies: Artificial Intelligence Brings Real Results
Leaders at AbelsonTaylor Group say the agency is harnessing AI-enabled messaging tools through a custom-built AI platform called Lexi. Lexi...
In the News Read more Annual Report Healthcare Communications Agencies: Artificial Intelligence Brings Real ResultsMedAdNews Agency Profile 2025: AbelsonTaylor Group
MedAdNews profiles AbelsonTaylor Group in its annual Agency Issue, highlighting AT Group’s “significant market wins,” new AI tools and initiatives...
In the News Read more MedAdNews Agency Profile 2025: AbelsonTaylor GroupAs Bluesky continues to grow, opportunities abound for pharma brands
With over 30 million users, Bluesky Social is quickly gaining steam. Associate Director of Engagement Helen Hoye recently spoke to...
In the News Read more As Bluesky continues to grow, opportunities abound for pharma brandsConnect with us
Find out what's top of mind for the people reimagining health and wellness advertising.